퀘이사의 팜

UPDATE: Teva stock tumbles premarket as earnings and guidance fall short of estimates

Teva Pharmaceutical Industries Ltd. shares TEVA, +1.59% tumbled 11% in premarket trade Wednesday, after the Israeli generics company missed earnings estimates for the fourth quarter and offered guidance that was also below consensus. The company said it had a net loss of $2.940 billion, or $2.85 a s...

www.marketwatch.com